-
admin
Posts
Opportunities in the $750+ Million Facial Mask Maker Industry, 2026-2032 | Rising Demand for DIY Skincare and Customization Solutions Drives Interest
Facial mask makers offer personalized, eco-friendly skincare solutions aligning with trends in clean beauty and sustainability. Their appeal lies in smart tech features, customization, and...
DNA-based Skin Care Products – Global Market Outlook (2026-2032) Featuring Profiles of 20+ Industry Players Including MyGenetics, Novogenia, SkinDNA, and Timeblock
The convergence of personal genomics and advanced dermatological science is creating key market opportunities in the DNA-based skin care industry Dublin, May 19, 2026 (GLOBE...
Global Dermocosmetics Market Report 2026 | Total Revenue to Reach $108 Billion by 2032 | Collaborations Between Dermatologists and Cosmetic Brands Strengthen Clinical Credibility
Dublin, May 19, 2026 (GLOBE NEWSWIRE) — The “Dermocosmetics – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Dermocosmetics...
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategy OCALA, Fla., May 19, 2026 (GLOBE NEWSWIRE) — AIM...
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) — Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and...
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building Proven track record advancing multiple therapeutics...
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience, mobility technologies, and metabolic disease...
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) — Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development,...
Following OCC Conditional Approval, Augustus Announces Column’s Benjamin Alexander as Chief Compliance Officer
Augustus names Benjamin Alexander as Chief Compliance Officer, bringing 15+ years of BSA/AML and regulatory compliance leadership from Column, HSBC, and JPMorgan Chase to architect...
AmChamSG Recognizes Inaugural Green Planet Champions
2026 AmChamSG Green Planet Energy Forum celebrates leadership and commitment to advancing a more sustainable and resilient energy future. SINGAPORE, May 19, 2026 /PRNewswire/ —...
